Schering-Plough Corporation today announced the launch of two multinational clinical trial, and an historic marker conveyance in support of AERIUS (desloratadine) bordered by the European Union (EU).Ã The ACCEPT (AERIUS Control: Clinical and Epidemiological Profile of Tablets) trials will weigh impervious the efficacy, impact on crown of aspect of enthusiasm, effectiveness, and pharmacoeconomics [...]
Entries from April 2009
AERIUS Now Approved For Use In Intermittent And Persistent Allergic Rhinitis
April 7th, 2009 · No Comments
Tags: Uncategorized
